Haemonetics Displays Small, Cartridge-Based TEG 6s Hemostasis Analyzer at AACC Clinical Lab Expo
By LabMedica International staff writers Posted on 29 Sep 2021 |
Haemonetics Corporation (Boston, MA, USA) displayed its small, cartridge-based TEG 6s hemostasis analyzer at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s premier gathering of clinical lab professionals from around the world.
Haemonetics provides blood management solutions to help improve care & reduce costs. The company’s TEG 6s system addresses the limitations of traditional testing by delivering fast, comprehensive, & functional assessment of coagulation. The analyzer’s easy-to-use test cartridge delivers a rapid, comprehensive picture of patient hemostasis giving invaluable insight. With a small footprint, robust quality control processes, vibration resistance, and simple, automated cartridge the TEG 6s can be readily deployed in varied settings.
Alongside the TEG 6s hemostasis analyzer, Haemonetics also demonstrated the TEG Manager software that allows secure, real time remote access to patient results, analyzer/user admin & LIS/POC system connectivity. The TEG Manager software system delivers convenient, secure TEG analyzer results viewing and system administration. It provides for robust TEG analyzer data warehousing, real-time, on-demand remote patient results viewing, clinical report generation, LIS connectivity, and user/device management/reporting. The Interpretation Guidance module allows clinicians the option to customize clinical alert messages according to your institution’s guidelines. It displays active and historical TEG results wherever/whenever within the hospital network. It also provides administrative functions including dashboard views of the status of all TEG analyzers throughout the hospital, manage users/access, and a robust suite of operational and audit reporting.
Related Links:
Haemonetics Corporation
Latest AACC 2021 News
- Study Showing Differing COVID-19 Antibody Profiles Among Vaccinated and Naturally Infected Individuals Presented at AACC 2021
- Study Reveals Varying Antibody Responses and Adverse Reactions Among Recipients of Different COVID-19 Vaccines
- Novel Study on Performance of Coronavirus Tests in Children Presented at 2021 AACC Annual Scientific Meeting
- New Rapid Test That Identifies Deteriorating COVID-19 Patients with Greater Accuracy than Existing Tests Presented at AACC 2021
- New Blood Test for Occupational Stress Identifies Healthcare Professionals Burned out from COVID-19 Pandemic
- New Non-Invasive Saliva Test for Early and Accurate Detection of Prostate Cancer Presented at AACC 2021
- New Non-Invasive Blood Test for Colon Cancer Presented at 2021 AACC Annual Scientific Meeting
- Study Establishing Accurate Reference Intervals for Pregnant Patients Presented at AACC 2021
- New Test that Measures Antibodies in Girls Who Have Received HPV Vaccine Presented at AACC 2021
- Novel Insights on COVID-19 Vaccines and Virus Evolution, AI in the Clinic, and Miniaturization of Diagnostic Platforms Explored at AACC 2021
- Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
- Group K Diagnostics Demonstrates KromaHealth Kit that Enables Lab-Quality Results at Point-of-Care
- NGeneBio Showcases NGS-Based Oncology/Genetic Diseases Kits and NGenePlex nCoV qRT-PCR Kit Against COVID-19
- Visby Medical Presents New Portable PCR COVID-19 Test Kit at 2021 AACC Annual Scientific Meeting & Clinical Lab Expo
- Fluxergy Introduces First-of-Its-Kind Multi-Modal Laboratory Platform That Diagnoses COVID-19 On-Site in 60 Minutes
- Mammoth Biosciences Presents AACC 2021 Disruptive Technology Award Finalist CRISPR-Based Detection Platform